2576 — Zhejiang Taimei Medical Technology Co Balance Sheet
0.000.00%
- HK$2.71bn
- HK$1.48bn
- CNY512.54m
Annual balance sheet for Zhejiang Taimei Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,400 | 1,408 | 1,068 | 1,199 | 1,192 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 156 | 199 | 209 | 218 | 228 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,592 | 1,660 | 1,326 | 1,477 | 1,470 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 110 | 84.9 | 41.3 | 35.2 | 22.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,805 | 1,825 | 1,445 | 1,583 | 1,556 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 350 | 391 | 358 | 293 | 328 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 394 | 515 | 466 | 425 | 434 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,411 | 1,310 | 978 | 1,158 | 1,122 |
| Total Liabilities & Shareholders' Equity | 1,805 | 1,825 | 1,445 | 1,583 | 1,556 |
| Total Common Shares Outstanding |